News
CNGGF
0.0015
NaN%
--
Weekly Report: what happened at CNGGF last week (0525-0529)?
Weekly Report · 3d ago
Weekly Report: what happened at CNGGF last week (0518-0522)?
Weekly Report · 05/25 09:58
Cann Group Seeks ASX Quotation for 16 Million New Shares
TipRanks · 05/22 05:02
Weekly Report: what happened at CNGGF last week (0511-0515)?
Weekly Report · 05/18 09:57
Weekly Report: what happened at CNGGF last week (0504-0508)?
Weekly Report · 05/11 09:55
Cann Group CEO exits as debt-cutting turnaround paves way for next phase
TipRanks · 05/05 00:12
Weekly Report: what happened at CNGGF last week (0427-0501)?
Weekly Report · 05/04 09:54
Cann Group seeks ASX quotation for over 13 million new shares
TipRanks · 05/01 04:58
Cann Group steps up European push as U.S. policy shift lifts medicinal cannabis outlook
TipRanks · 04/29 00:34
Weekly Report: what happened at CNGGF last week (0420-0424)?
Weekly Report · 04/27 09:55
Weekly Report: what happened at CNGGF last week (0413-0417)?
Weekly Report · 04/20 09:53
Cann Group to List 15.4 Million New Shares on ASX
TipRanks · 04/15 05:42
Weekly Report: what happened at CNGGF last week (0406-0410)?
Weekly Report · 04/13 09:56
Weekly Report: what happened at CNGGF last week (0330-0403)?
Weekly Report · 04/06 09:55
Weekly Report: what happened at CNGGF last week (0323-0327)?
Weekly Report · 03/30 09:56
Weekly Report: what happened at CNGGF last week (0316-0320)?
Weekly Report · 03/23 09:53
Cann Group secures A$750,000 via Obsidian convertible notes
TipRanks · 03/18 05:28
Cann Group Issues 527,100 Unquoted Convertible Notes
TipRanks · 03/18 04:57
Cann Group Issues New Shares Under Convertible Securities Deal
TipRanks · 03/18 02:07
Cann Group Seeks ASX Quotation for 8.4 Million New Shares
TipRanks · 03/18 02:07
More
Webull provides a variety of real-time CNGGF stock news. You can receive the latest news about Cann Group through multiple platforms. This information may help you make smarter investment decisions.
About CNGGF
Cann Group Limited is an Australia-based company, which is focused on developing, producing, and supplying innovative cannabis medicines. The principal activities of the Company include the cultivation of medicinal cannabis for both medicinal and research purposes pursuant to the licenses and permits issued to the Company, the development and manufacture (via third party arrangements) of finished product formulations, and the pursuit and execution of various supply agreements with third parties. It operates through cultivation of the medicinal cannabis segment. The Company supplies a range of dried flower and oil products, as well as active pharmaceutical ingredients and extracts, to customers in Australia and around the world. It also owns Satipharm and its patent-protected capsule technology. The Company's research and good manufacturing practices (GMP) manufacturing facilities are near Mildura, Victoria.